FADS2 rs17457033: Modulating Polyunsaturated Fatty Acid Levels
The genetic variant rs17457033 is a single-nucleotide polymorphism located within the FADS1-FADS2 fatty acid desaturase gene cluster on chromosome 11. It is statistically associated with variations in how the body processes dietary fats, particularly modulating circulating levels of long-chain polyunsaturated fatty acids (LC-PUFAs). Evidence evaluating this specific locus indicates a limited but biologically plausible role in altering precursor-to-product fatty acid ratios.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| Major Allele Homozygote | Carriers of two copies of the common ancestral allele typically demonstrate standard delta-6 desaturase enzymatic activity. Research associates this genotype with conventional baseline conversion rates of precursor fatty acids into downstream long-chain polyunsaturated fatty acids. Circulating metabolite ratios generally align with population reference averages. | Informational |
| Heterozygote | Carriers of one major and one minor allele have an intermediate genetic profile for fatty acid desaturation efficiency. Metabolic studies indicate subtle shifts in substrate-to-product PUFA ratios compared to baseline averages. These modest biochemical differences generally do not produce noticeable symptoms or standalone health consequences. | Informational |
| Minor Allele Homozygote | Individuals carrying two copies of the minor allele are statistically associated with reduced endogenous conversion efficiency in the FADS pathway. This profile typically correlates with higher relative amounts of precursor fatty acids and lower circulating proportions of long-chain desaturation products. This statistical trait represents a biochemical pattern rather than a medical condition. | Higher attention |
Genomic Context and the FADS Cluster
The single nucleotide polymorphism rs17457033 is located on human chromosome 11 within the fatty acid desaturase gene region, mapped closely to the FADS2 gene. This genomic segment exists in a tight block of high linkage disequilibrium spanning FADS1, FADS2, and FADS3. Because polymorphisms across this cluster are frequently inherited together, individual variants like rs17457033 often mirror broader haplotype effects observed across the entire desaturase locus. In standard human sequencing builds, variants in this cluster represent single base-pair substitutions that regulate transcriptional activity or alternative splicing of the desaturase enzymes.
Biological Role of FADS2 in Fatty Acid Metabolism
The FADS2 gene encodes the enzyme delta-6 desaturase, an essential, rate-limiting catalyst in the endogenous biosynthesis of long-chain polyunsaturated fatty acids. Delta-6 desaturase introduces double bonds into carbon chains of dietary plant-derived precursors, converting linoleic acid into gamma-linolenic acid in the omega-6 pathway, and alpha-linolenic acid into stearidonic acid in the omega-3 pathway. These intermediate metabolites eventually undergo further elongation and desaturation to form crucial structural lipids and bioactive molecules, including arachidonic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
Research Associations and Evidence Strength
Genome-wide and candidate gene association studies have consistently shown that variants across the FADS cluster influence circulating levels and membrane incorporation of polyunsaturated fatty acids. Individuals carrying minor alleles in this cluster typically exhibit lower enzymatic efficiency, reflected by higher precursor substrate concentrations and lower downstream product ratios. However, specific direct evidence for rs17457033 as an independent causal driver remains limited, as its measured effects are largely attributable to strong co-inheritance with well-characterized sentinel markers in the region.
Ancestry and Population Frequencies
The distribution of alleles within the FADS gene cluster varies markedly among global populations due to past evolutionary pressures and dietary adaptations. For rs17457033, the minor allele frequency is estimated between 0.25 and 0.35 in European and Asian ancestral cohorts. In contrast, ancestral populations with traditional diets differing substantially in marine or plant fat composition often display distinct allele frequencies across linked desaturase variants, reflecting regional natural selection on lipid processing efficiency.
Clinical Utility and Interpretation Limits
Knowing your rs17457033 genotype provides biochemical insight into statistical tendencies in lipid conversion rather than a clinical diagnosis. This variant does not cause disease on its own, nor does it establish definitive dietary deficiencies. Readers should not use direct-to-consumer genetic findings to alter prescription therapies, discontinue medications, or adopt extreme nutritional regimens. Any potential dietary changes or questions regarding cardiovascular and metabolic lipid profiles should always be discussed directly with a qualified physician or registered dietitian.
How common is this variant?
The minor allele frequency for rs17457033 is approximately 0.25 to 0.35 in European and Asian ancestries. Across diverse global populations, variations in the surrounding FADS cluster reflect substantial ancestral divergence linked to historical dietary lipid intake.
Frequently asked questions
Does having the rs17457033 variant mean I have a fatty acid deficiency?
No. The variant is simply a common genetic marker associated with differences in the rate at which your body converts shorter precursor fats into longer fatty acids. It does not mean you have an active nutrient deficiency or any medical disorder.
Can rs17457033 indicate whether I should take fish oil supplements?
Genetics alone cannot determine nutritional supplementation needs. While variants in FADS2 influence internal lipid conversion rates, total nutrient status depends heavily on overall diet, health history, and baseline blood work evaluated by a healthcare professional.
Why is the evidence for rs17457033 considered limited?
The FADS region consists of many tightly linked genetic markers inherited as a single block. While the broader FADS1-FADS2 region is known to regulate polyunsaturated fats, studies isolating rs17457033 as an independent causal variant rather than a co-inherited proxy remain limited.
Can I use my rs17457033 results to change my medications?
No. Genotype data for rs17457033 should never be used to alter, start, or stop prescribed treatments. Always consult your prescribing doctor or pharmacist before making any changes to lipid-lowering therapies or cardiovascular medications.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17457033?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29